Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A May 6, 2022
8-K May 5, 2022
3 May 4, 2022 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
DEFA14A May 2, 2022
DEF 14A May 2, 2022
8-K Mar 31, 2022
10-K Mar 31, 2022
4 Feb 24, 2022
4 Feb 24, 2022
4 Feb 24, 2022
3 Feb 15, 2022
SC 13G/A Feb 14, 2022
SC 13G/A Feb 14, 2022 AMENDMENT NO. 2
3 Feb 9, 2022
8-K Feb 8, 2022
4 Feb 4, 2022
4 Feb 4, 2022
4 Feb 4, 2022
4 Feb 4, 2022
4 Feb 4, 2022
4 Feb 4, 2022
4 Feb 4, 2022
4 Feb 4, 2022
S-8 Jan 31, 2022
8-K Jan 27, 2022
← Newer Page 12 of 23 · 551 filings Older →